Page 26 - Michael Yee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(Reuters) -Moderna on Wednesday said its flu vaccine had generated a stronger immune response against all four A and B strains of the influenza virus compared to traditional flu shots in a late-stage trial, sending shares up about 6% in early trading. The effectiveness of Moderna's flu vaccine was demonstrated across all age groups, including older people, and was found to be safe and tolerable, according to the company. Moderna also said it had found that its shot was equal or superior to Sanof

The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of Horizon Therapeutics was the latest setback to its stated goal of stricter antitrust enforcement, and instead paved the way for Amgen to gain drugs not subject to new price negotiations and possibly lower the company's tax burden. The move signals the FTC's uncertainty that a court would support its novel theory of future competition being disadvantaged by Amgen's "bundling" of drugs in negotiations with insurers. "I think there is some skittishness on whether to pursue...

On Friday, the U.S.

The newest version of the COVID-19 vaccine will be available by the end of September, according to the CDC.

A new Covid vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations f...